Equillium Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

The commencement of Phase 1 proof-of-mechanism research for EQ504 is anticipated to begin in the fourth quarter of 2026. Following this, data from the study is expected around six months later.